Charles Cherington serves as Executive at Brooklyn ImmunoTherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Charles Cherington has executed 15 insider transactions totaling $9.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 11, 2023 involved purchasing 2,053,789 shares valued at $1.0M.
Charles Cherington currently holds 5,813,650 shares of Brooklyn ImmunoTherapeutics, Inc. (BTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Cherington has been a net seller of BTX stock. They have purchased $3.4M and sold $6.3M worth of shares.
Charles Cherington's most recent insider trade was on Sep 11, 2023, when they purchased 2,053,789 shares at $0.51 per share.
Get notified when new Form 4 filings are submitted
| $0.51 |
| Discretionary |
| Jan 4, 2023 | CMRA | $914.2K | Purchase | 743,243 | $1.23 | Discretionary |
| Dec 2, 2022 | ERNA | $858.6K | Purchase | 261,756 | $3.28 | Discretionary |
| Oct 21, 2022 | CMRA | $18.6K | Purchase | 11,691 | $1.59 | Discretionary |
| Oct 20, 2022 | CMRA | $5.0K | Purchase | 3,316 | $1.52 | Discretionary |
| Oct 17, 2022 | CMRA | $25.3K | Purchase | 15,266 | $1.66 | Discretionary |
| Oct 14, 2022 | CMRA | $6.8K | Purchase | 4,253 | $1.60 | Discretionary |
| Oct 13, 2022 | CMRA | $17.4K | Purchase | 10,481 | $1.66 | Discretionary |
| Sep 29, 2022 | CMRA | $33.5K | Purchase | 17,900 | $1.87 | Discretionary |
| Sep 27, 2022 | CMRA | $20.3K | Purchase | 12,000 | $1.69 | Discretionary |
| Jun 17, 2021 | BTX | $3.1M | Sale | 198,000 | $15.74 | Discretionary |
| Jun 17, 2021 | BTX | $32.6K | Sale | 2,000 | $16.30 | Discretionary |
| Jun 16, 2021 | BTX | $3.1M | Sale | 200,000 | $15.73 | Discretionary |
| Jun 1, 2021 | BTX | $0 | Other | 92 | $N/A | Discretionary |